SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on July 22, 2014. The registrant is incorporated in Delaware and maintains its principal executive offices in Los Angeles, California. The report addresses corporate governance updates rather than periodic financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or operational metrics.
Material Changes
The primary material event reported is the appointment of Patrick Gallagher to the Company's board of directors, announced via a press release on July 22, 2014. No financial or operational changes were disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document strictly reports the board appointment and lists the associated press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for details on Patrick Gallagher's background and specific role.
- Confirm the current composition of the Board of Directors following this appointment.
- Review the most recent 10-Q or 10-K filing for actual financial performance data, as this 8-K does not include it.